Literature DB >> 2542206

Transformation of NIH3T3 cells with synthetic c-Ha-ras genes.

H Kamiya1, K Miura, N Ohtomo, T Koda, M Kakinuma, S Nishimura, E Ohtsuka.   

Abstract

Synthetic human c-Ha-ras genes in which amino acid codons were altered to those which are frequently used in highly expressed Escherichia coli genes were ligated to the 3'-end of Rous sarcoma virus long terminal repeat. When NIH3T3 cells were transfected with the plasmids having those genes with valine at codon 12, leucine at codon 61 or arginine at codon 61, transformants were efficiently produced. These results indicated that the synthetic c-Ha-ras genes are expressed in a mammalian system even though their codon usage is altered to correspond with that of E. coli. This expression vector system should be useful for studies on the structure-function relationships of c-Ha-ras, since the synthetic gene can be easily modified to have multiple base alterations, and can also be used simultaneously for the production of large amounts of p21 in E. coli for biochemical and biophysical studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542206      PMCID: PMC5917723          DOI: 10.1111/j.1349-7006.1989.tb02291.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.

Authors:  A M de Vos; L Tong; M V Milburn; P M Matias; J Jancarik; S Noguchi; S Nishimura; K Miura; E Ohtsuka; S H Kim
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

Review 2.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 3.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

7.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

8.  Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient.

Authors:  T Sekiya; M Fushimi; H Hori; S Hirohashi; S Nishimura; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

10.  High efficiency DNA-mediated transformation of primate cells.

Authors:  C Gorman; R Padmanabhan; B H Howard
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

View more
  6 in total

1.  An abasic site analogue activates a c-Ha-ras gene by a point mutation at modified and adjacent positions.

Authors:  H Kamiya; M Suzuki; Y Komatsu; H Miura; K Kikuchi; T Sakaguchi; N Murata; C Masutani; F Hanaoka; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Cyclobutane thymine dimers in a ras proto-oncogene hot spot activate the gene by point mutation.

Authors:  H Kamiya; N Murata; T Murata; S Iwai; A Matsukage; C Masutani; F Hanaoka; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

3.  c-Ha-ras down regulates the alpha-fetoprotein gene but not the albumin gene in human hepatoma cells.

Authors:  K Nakao; D Lawless; Y Ohe; Y Miyao; H Nakabayashi; H Kamiya; K Miura; E Ohtsuka; T Tamaoki
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

Review 4.  8-Hydroxyguanine: From its discovery in 1983 to the present status.

Authors:  Susumu Nishimura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-05       Impact factor: 3.493

5.  Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.

Authors:  D J Peace; J W Smith; W Chen; S G You; W L Cosand; J Blake; M A Cheever
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

6.  Transforming activity of a synthetic c-Ha-ras gene containing O6-methylguanine in codon 12.

Authors:  H Kamiya; K Miura; N Ohtomo; S Nishimura; E Ohtsuka
Journal:  Jpn J Cancer Res       Date:  1991-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.